November 2023 - Page 3 of 5

ThursdayNov 16, 2023 10:30 am

Freight Technologies Inc. (NASDAQ: FRGT) CEO Underscores Commitment to Continued Growth in Letter to Shareholders

Fr8Tech CEO recently wrote a letter to shareholders summarizing the company’s financial milestones and operational successes CEO Javier Selgas discussed the company’s robust revenue growth in Q2 2023 as well as the 93% year-over-year increase in its gross margins during the first half of the year The company’s commitment to innovation has led to the launch of an LTL offering and the establishment of an AI department Fr8Tech has successfully expanded into new markets, completed a number of strategic integrations with third-party solutions, and grown its customer base Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a technology company whose lead product is…

ThursdayNov 16, 2023 9:45 am

Clene Inc. (NASDAQ: CLNN) Reports Q3 2023 Financial Results, Recent Operating Highlights for Its ALS Clinical Program

Clene recently released its financial results for the third quarter ended September 30, 2023, and provided recent operating highlights for its ALS clinical program The ALS clinical program includes two independent studies evaluating the safety and efficacy of the company’s lead investigational product CNM-Au8(R) The 24-month long-term data cut from the open-label extension of the RESCUE-ALS study showed a significant median survival benefit of 19.3 months, a significant 52% decreased risk of ALS clinical worsening events, and a 75% decreased risk of long-term all-cause mortality Clene also summarized long-term follow-up data from the HEALEY ALS platform trial, which demonstrated significantly…

WednesdayNov 15, 2023 9:45 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) To Quantify Previous Attributes of its RapidSX(TM) Technology Platform Following Technical Update on Louisiana Demo Plant

Ucore, a company engaged in the exploration for plus separation and scalable production of REEs, just announced a technical update on its RapidSX(TM) Demonstration Plant in Kingston, Ontario Mike Schrider, the company’s VP and COO, lauded this milestone, noting how it ultimately led to optimizing the chemistry delivery and feedback systems to and from the RapidSX(TM) platform within the plant These steps will lead the way to demo plant commercialization, scale-up, and technology transfer, for its developing 7,500 tonnes per annum (ex-cerium and ex-yttrium) REE separation plant - the Louisiana Strategic Metals Complex ("LA-SMC") in Alexandria, Louisiana Ucore Rare Metals…

WednesdayNov 15, 2023 9:00 am

SuperCom Ltd. (NASDAQ: SPCB) Extends Support for California’s Criminal Justice System with New Alcohol Monitoring Contract, Valued at up to $3M Over Initial 3-year Term

SuperCom’s wholly owned subsidiary, Leaders in Community Alternatives, Inc. (“LCA”), recently won a new contract to supply alcohol monitoring technologies and services in California The contract is valued at up to $3 million over the initial 3-year term, based on anticipated usage estimates Since 2003, LCA has provided continuous transdermal alcohol monitoring (“CAM”) programs for thousands of California drivers found driving under the influence (“DUI”) The alcohol monitoring programs use tamper-proof tags worn around the ankle to measure the amount of alcohol in an offender’s body by taking a sample of their sweat every 30 minutes SuperCom’s reputation for providing…

TuesdayNov 14, 2023 9:30 am

PaxMedica Inc. (NASDAQ: PXMD) Is Hoping to Boost Patient Independence with Potential ASD Treatment Amid Growing Prevalence Rates

PaxMedica is developing PAX-101, which utilizes the company’s proprietary source of suramin sodium, for the treatment of ASD (Autism Spectrum Disorder) There is no FDA-approved treatment for the core symptoms of autism, even though the rates of autism spectrum disorder have jumped significantly from 2000 to 2020 ASD is characterized by deficits in social communication, restricted and repetitive patterns of behavior, and significant impairment in functioning, three core aspects of the disease that PaxMedica aims to address The company announced positive topline results from a Phase 2 study evaluating PAX-101 as a potential treatment for ASD and hopes to replicate…

TuesdayNov 14, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyes $200 Billion GLP-1 Market with its DehydraTECH(TM) Technology

Lexaria, a global innovator in drug delivery platforms, is exploring the impact of its patented DehydraTECH(TM) technology on the oral performance of GLP-1 drugs for potential diabetes and weight loss treatment The company hopes to make these drugs more effective with reduced side effects, and even more accessible to people living with diabetes The move is aimed to help the company partner with the behemoths in an industry projected to bring in between $150 billion and $200 billion a year Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is evaluating the impact of its patented DehydraTECH(TM) technology…

MondayNov 13, 2023 10:30 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) on Mission to Bring Rare Earth Separation Facilities to North America

The rare earth metals market was valued at $5.3 billion in 2021 and is projected to grow at a CAGR of 12.3%, resulting in a value of $9.6 billion by 2026 The growing tensions between China and the United States make it more important than ever for sustainable REE (Rare Earth Element) separation operations that do not depend on China, and Ucore's RapidSX(TM) technology is key to the answer Ucore plans is developing its first Strategic Metals Complex for REE separation in Louisiana The demand for rare earth elements (“REE”) is expected to surge as the electric vehicle and renewable…

MondayNov 13, 2023 9:45 am

Diamond Lake Minerals Inc. (DLMI) Bridges Gap Between Old-school Business Models, New-school Digital Assets

Utah-based Diamond Lake Minerals Inc. is a vertically integrated company focused on digital assets and securities, focused on building and acquiring enterprises in sectors ranging from music and entertainment to real estate, healthcare, and digital tokens The company has welcomed a new CEO and several new strategic advisors since late August, building market value to $84 million in market cap One of DLMI’s aims is to be a “hybrid missing piece”, getting generational wealth to overcome modernization acquisition hurdles and become involved in the digital assets space Multi-strategy operating company Diamond Lake Minerals (OTC: DLMI) is building a digital vision…

MondayNov 13, 2023 9:00 am

SenesTech Inc. (NASDAQ: SNES) Begins Taking Orders for their new Soft Bait Rodent Contraceptive That Provides Unique Approach to Pest Control

Arizona-based SenesTech Inc. provides a unique approach to rodent pest control by formulating a contraceptive that works as birth control in both male and female rats A major milestone has been reached by the company as it recently began taking orders for its new Evolve(TM) Soft Bait formulation, which joins SenesTech’s liquid ContraPest(R) brand as a population-control solution that avoids some of the problems associated with lethal rodenticides The Evolve(TM) Soft Bait product is targeting the vast professional pest control market that prefers a non-liquid product, as well as providing a consumer-friendly option that may be marketed through big box…

FridayNov 10, 2023 9:45 am

Clene Inc. (NASDAQ: CLNN) Among Grant Awardees Selected to Advance Scientific Research on ALS

Clene, a company targeting the treatment of neurodegenerative diseases that severely impact people’s lives, is currently focusing on amyotrophic lateral sclerosis (“ALS”) alongside other neurodegenerative diseases The company’s wholly owned subsidiary, Clene Nanomedicine, and two collaborators, Columbia University and Synapticure, are the recipients of a four-year grant totaling $45.1 million The grant will support an Expanded Access Protocol (“EAP”) study for Clene’s investigational product, CNM-Au8(R) CNM-Au8 is an orally administered gold nanocrystal suspension that is thought to improve mitochondrial health and protect neuronal function to treat neurodegenerative diseases, including ALS The EAP study will give patients who did not initially…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

Month: November 2023